Paracervical Block as a Strategy to Reduce Postoperative Pain after Laparoscopic Hysterectomy: A Randomized Controlled Trial.

Abstract

STUDY OBJECTIVE:

To determine if performing a paracervical block with .5% bupivacaine before laparoscopic hysterectomy reduces postoperative pain.

DESIGN:

Double-blind randomized controlled trial (Canadian Task Force classification I).

SETTING:

University-affiliated hospital.

PATIENTS:

Women aged between 18 and 65 years scheduled to undergo total laparoscopic hysterectomy for benign indications.

INTERVENTIONS:

Eligible patients were allocated to control or treatment groups using block randomization. Surgeon administered injection of either .9% NaCl or .5% bupivacaine into the cervical stroma at the 3 and 9 o'clock positions after general anesthesia was established. Pain was assessed using a visual analog scale with a range from 0 to 10 at 30 and 60 minutes after extubation.

MEASUREMENTS AND MAIN RESULTS:

Forty-one patients met criteria for analysis. Based on randomization, 20 were allocated to the control arm and 21 to the treatment arm. We used Student t and Pearson χ2 tests to ensure both groups were homogenous to age (46.5 vs 46, p = .87), body mass index (35 vs 32.7 kg/m2, p = .45), minutes of operating time (132.5 vs 119.7, p = .11), specimen weight (138.8 vs 160.6 g, p = .44), and history of cesarean section (p = .58). Pain scores at 30 minutes (5.7 vs 3.2, p = .01) and 60 minutes (5.9 vs 2.3, p <.001) were significantly lower in the treatment arm. We dichotomized results depending on whether patients had successful postoperative pain control, defined as an average pain score of 4 or less. The χ2 test was used for comparison. Using this definition 25% of patients had successful pain control in the placebo group versus 71.4% in the treatment group. This was statistically significant (p = .003). Mean length of hospital stay (.65 vs .86 days, p = .44) was not statistically different.

CONCLUSION:

Performing a paracervical block with .5% bupivacaine before laparoscopic hysterectomy significantly reduces immediate postoperative pain. (ClinicalTrials.gov no.: NCT03027661.).

• Authors: Steven Radtke, Todd Boren, Stephen Depasquale
• Journal: Journal of minimally invasive gynecology (J Minim Invasive Gynecol) 2019 Sep - Oct Vol. 26 Issue 6 Pg. 1164-1168 ISSN: 1553-4669 [Electronic] United States
• PMID: 30528725 (Publication Type: Journal Article, Randomized Controlled Trial)
• Copyright: Copyright © 2019. Published by Elsevier Inc.

Chemical References

• Anesthetics, Local
• Bupivacaine

Topics

• Adolescent
• Adult
• Aged
• Anesthesia, General
• Anesthesia, Obstetrical (methods)
• Anesthetics, Local (administration & dosage, adverse effects)
• Bupivacaine (administration & dosage, adverse effects)
• Double-Blind Method
• Female
• Humans
• Hysterectomy (adverse effects, methods)
• Laparoscopy (adverse effects, methods)
• Length of Stay
• Middle Aged
• Operative Time
• Pain Management (methods)
• Pain Measurement
• Pain, Postoperative (etiology, prevention & control)
• Preoperative Care (methods)
• Uterine Diseases (surgery)
• Young Adult